LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
  • Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

    Investing Articles

    Is Hikma Pharmaceuticals the hottest growth stock in the FTSE 250?

    FTSE 250 (INDEXFTSE: MCX) growth stock Hikma Pharmaceuticals plc (LON: HIK) is up 120% since March. Are there more gains…

    Read more »

    Investing Articles

    Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc

    I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Why is the Burberry share price up 20% so far this year?

    Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround.

    Read more »

    Investing Articles

    2 super growth stocks I’d buy with £5,000 today

    Just £5,000 could help you make a fortune with these super growth stocks.

    Read more »

    Investing Articles

    2 cheap growth stocks I’d buy for the long term

    These two shares could offer a mix of growth and value in current market conditions.

    Read more »

    Investing Articles

    2 FTSE 250 pharma stocks I’d buy today and hold for another five years

    Roland Head takes a look at two unusual pharma stocks with long-term growth potential.

    Read more »

    Investing Articles

    Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

    G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys.

    Read more »

    Investing Articles

    Two defensive growth stocks I’d buy and hold for 10 years

    These two stocks are struggling today but the future could still be bright.

    Read more »

    Investing Articles

    2 turnaround stocks I’d consider buying before 2018

    Could these two turnaround stocks beat the market in 2018 and beyond?

    Read more »

    Investing Articles

    Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

    Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results.

    Read more »

    Investing Articles

    Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

    I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

    Read more »

    Investing Articles

    2 growth stocks for the long run

    These two stocks could perform well in future years.

    Read more »